BRD4 is reported to be upregulated in other oncogenic signaling and cancer stem cell (CSC) signaling such as Hh pathways Gli‐1 (Tang et al., 2014) and Jagged1/Notch1 (Andrieu et al., 2016). The gene discussed is BRD4; the disease is cancer.